PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.310
+0.060 (4.80%)
May 19, 2026, 4:00 PM EDT - Market closed
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $69.86 million as of May 19, 2026. Its market cap has increased by 43.22% in one year.
Market Cap
69.86M
Enterprise Value
-23.39M
1-Year Change
43.22%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $69.86M, a decrease of -95.67%. That is a compound annual growth rate of -42.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 69.86M | 5.03% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 73.99M |
| Alterity Therapeutics | 73.90M |
| XBiotech | 72.26M |
| Seres Therapeutics | 72.05M |
| Pliant Therapeutics | 71.21M |
| Acrivon Therapeutics | 68.48M |
| MediciNova | 68.42M |
| Gain Therapeutics | 67.82M |